{
    "hands_on_practices": [
        {
            "introduction": "Diagnosing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) can be complex due to its heterogeneous presentation. To standardize the diagnostic process, the Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) developed a validated scoring system. This first exercise  provides a practical opportunity to apply these criteria to a realistic clinical vignette, honing the meticulous attention to detail required to accurately classify a suspected case.",
            "id": "4436862",
            "problem": "A hospitalized adult develops suspected Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). You are provided the following clinically verified features: fever of $39^{\\circ}\\mathrm{C}$, a generalized morbilliform eruption involving $70\\%$ of total body surface area, an absolute eosinophil count of $1.3\\times 10^{9}\\,\\mathrm{L}^{-1}$, atypical lymphocytes present on peripheral smear, cervical lymphadenopathy localized to one anatomical region, alanine aminotransferase (ALT) at $3\\times$ the upper limit of normal, and complete resolution of the eruption and systemic findings at $28$ days from onset. No skin biopsy was performed; rash morphology beyond extent is not specified; and no laboratory testing to exclude other infectious or autoimmune etiologies was performed.\n\nUsing the Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) validation scoring framework according to its published criteria, determine the total RegiSCAR score and the case classification. Base your reasoning on core definitions of RegiSCAR items: fever threshold, lymphadenopathy site count, eosinophilia tiers, atypical lymphocytes, rash extent, organ involvement thresholds for hepatitis, resolution duration, and whether alternative causes were ruled out.\n\nProvide only the numerical RegiSCAR total as your final answer. No rounding is required; report the integer score.",
            "solution": "The problem requires the calculation of a total score for a suspected case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) using the Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) validation scoring framework. The validation of the problem statement confirms that it is scientifically grounded, well-posed, and objective, providing a clear set of clinical data to be applied to a standardized and published scoring system. The problem is therefore deemed valid.\n\nThe solution proceeds by systematically evaluating each piece of clinical information against the specific criteria of the RegiSCAR scoring system.\n\n1.  **Fever:** The patient's temperature is given as $39^{\\circ}\\mathrm{C}$. The RegiSCAR system awards $+1$ point for a fever $\\ge 38.5^{\\circ}\\mathrm{C}$. Since $39^{\\circ}\\mathrm{C} \\ge 38.5^{\\circ}\\mathrm{C}$, this criterion is met.\n    Score for fever: $+1$.\n\n2.  **Eosinophilia:** The patient's absolute eosinophil count is $1.3 \\times 10^{9}\\,\\mathrm{L}^{-1}$. The RegiSCAR criteria for eosinophilia are tiered: $+1$ point for a count $\\ge 0.7 \\times 10^{9}\\,\\mathrm{L}^{-1}$ and $< 1.5 \\times 10^{9}\\,\\mathrm{L}^{-1}$, and $+2$ points for a count $\\ge 1.5 \\times 10^{9}\\,\\mathrm{L}^{-1}$. The patient's count of $1.3 \\times 10^{9}\\,\\mathrm{L}^{-1}$ falls within the first tier.\n    Score for eosinophilia: $+1$.\n\n3.  **Atypical Lymphocytes:** The presence of atypical lymphocytes on the peripheral smear is noted. The RegiSCAR system awards $+1$ point for this finding.\n    Score for atypical lymphocytes: $+1$.\n\n4.  **Lymphadenopathy:** The patient has cervical lymphadenopathy localized to one anatomical region. The RegiSCAR criterion requires enlarged lymph nodes in $\\ge 2$ anatomical regions to award $+1$ point. Since only one region is involved, this criterion is not met.\n    Score for lymphadenopathy: $0$.\n\n5.  **Skin Involvement:** The rash involves $70\\%$ of the total body surface area (TBSA). The RegiSCAR system awards $+1$ point for a rash extent of $> 50\\%$ TBSA. Since $70\\% > 50\\%$, this criterion is met. No points can be awarded for rash morphology or biopsy findings as these were not specified or performed.\n    Score for skin involvement: $+1$.\n\n6.  **Internal Organ Involvement:** The patient's alanine aminotransferase (ALT) level is at $3 \\times$ the upper limit of normal (ULN). The RegiSCAR criterion for liver involvement is an ALT level $> 2 \\times$ ULN, which awards $+1$ point. Since $3 > 2$, this criterion is met for one organ. No other organ involvement is described. Therefore, the total score for organ involvement is for one organ.\n    Score for organ involvement: $+1$.\n\n7.  **Resolution Time:** The patient's eruption and systemic findings resolved in $28$ days. The RegiSCAR system awards $+1$ point for a resolution time $\\ge 15$ days. Since $28 \\ge 15$, this criterion is met.\n    Score for resolution time: $+1$.\n\n8.  **Evaluation of Other Causes:** The problem statement explicitly mentions that \"no laboratory testing to exclude other infectious or autoimmune etiologies was performed.\" The RegiSCAR system awards points for negative serologies (e.g., for hepatitis A, B, C) and other tests that help rule out alternative diagnoses. As these tests were not conducted, no points can be given for this category.\n    Score for evaluation of other causes: $0$.\n\n**Total Score Calculation:**\nThe total RegiSCAR score is the sum of the points from each category:\nTotal Score = (Fever) + (Eosinophilia) + (Atypical Lymphocytes) + (Lymphadenopathy) + (Skin Involvement) + (Organ Involvement) + (Resolution Time) + (Evaluation of other causes)\nTotal Score = $1 + 1 + 1 + 0 + 1 + 1 + 1 + 0 = 6$.\n\n**Case Classification:**\nBased on the total score, the RegiSCAR system classifies cases as follows:\n- Score $< 2$: No DRESS\n- Score $2-3$: Possible DRESS\n- Score $4-5$: Probable DRESS\n- Score $> 5$: Definite DRESS\n\nWith a total score of $6$, this case is classified as a **definite case** of DRESS. The problem asks only for the numerical total as the final answer.",
            "answer": "$$\n\\boxed{6}\n$$"
        },
        {
            "introduction": "Once DRESS is suspected, identifying and withdrawing the causative agent is the most critical intervention. This often requires careful clinical reasoning, as patients may have been started on multiple medications in the weeks preceding symptom onset. This problem  simulates this diagnostic challenge, requiring you to weigh the evidence based on drug-specific latency periods and known epidemiological risk factors to pinpoint the most likely culprit.",
            "id": "4436824",
            "problem": "A patient presents with fever, facial edema, diffuse morbilliform eruption with pustular accentuation, lymphadenopathy, eosinophilia, and transaminitis. Human herpesvirus 6 (HHV-6) polymerase chain reaction is positive from whole blood. The clinical diagnosis is Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). The recent medication history is: allopurinol started on day $0$, amoxicillin started on day $12$, and lamotrigine started on day $20$. The generalized eruption and systemic symptoms began on day $35$. Based solely on first principles of delayed T cell–mediated hypersensitivity kinetics, epidemiology of culprit drugs, and known mechanistic predispositions (e.g., Human Leukocyte Antigen (HLA)–restricted presentation and reactive metabolite formation), which of the following orderings ranks the most to least likely culprit and provides the best mechanistic and timing justification?\n\nA. Allopurinol $>$ Lamotrigine $>$ Amoxicillin; because a $35$-day latency aligns with the classic $3$–$6$ week window for allopurinol-associated DRESS driven by oxypurinol accumulation and HLA-B*58:01–restricted T cell recognition, lamotrigine (an aromatic anticonvulsant) has a typical $2$–$8$ week DRESS latency so $15$ days is plausible though toward the lower bound, and aminopenicillins only rarely cause DRESS and more commonly cause earlier benign exanthems.\n\nB. Lamotrigine $>$ Allopurinol $>$ Amoxicillin; because aromatic anticonvulsants are the dominant DRESS triggers regardless of latency, and the shorter $15$-day interval most strongly supports lamotrigine, while allopurinol is less likely without renal impairment.\n\nC. Amoxicillin $>$ Lamotrigine $>$ Allopurinol; because a $23$-day interval fits a delayed T cell response to a haptenated penicillin, lamotrigine generally requires coadministration with valproate for severe hypersensitivity, and allopurinol-triggered DRESS is unlikely without HLA-B*58:01 carriage.\n\nD. Lamotrigine $>$ Amoxicillin $>$ Allopurinol; because the shortest interval best supports causality in drug eruptions, and penicillins are a more frequent cause of DRESS than urate-lowering therapies.\n\nE. Allopurinol $>$ Amoxicillin $>$ Lamotrigine; because penicillin hypersensitivity is the second most common cause of DRESS after allopurinol, and lamotrigine is primarily associated with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) rather than DRESS.",
            "solution": "The problem asks to identify the most likely culprit drug for a diagnosed case of DRESS by ranking three potential medications: allopurinol, amoxicillin, and lamotrigine. This requires applying knowledge of drug-specific latency periods, epidemiological risk, and underlying mechanisms of DRESS. The problem is clinically realistic and scientifically well-posed.\n\nFirst, the latency period for each drug must be calculated, defined as the time from drug initiation to the onset of symptoms on day 35.\n*   **Allopurinol:** Started on day 0. Latency = $35 - 0 = 35$ days.\n*   **Amoxicillin:** Started on day 12. Latency = $35 - 12 = 23$ days.\n*   **Lamotrigine:** Started on day 20. Latency = $35 - 20 = 15$ days.\n\nNext, each drug's likelihood is evaluated based on these latencies and known DRESS characteristics.\n\n1.  **Allopurinol:**\n    *   **Latency:** A 35-day (5-week) latency is perfectly within the classic range of 2 to 8 weeks for DRESS. For allopurinol specifically, the mean latency is often around 3-4 weeks.\n    *   **Epidemiology:** Allopurinol is one of the most frequently implicated drugs in causing DRESS worldwide.\n    *   **Mechanism:** Allopurinol-induced DRESS is strongly associated with the HLA-B*58:01 allele. The latency reflects the time for accumulation of its metabolite, oxypurinol, and the subsequent priming and expansion of naive T-cells. Allopurinol is a very strong candidate.\n\n2.  **Lamotrigine:**\n    *   **Latency:** A 15-day (just over 2-week) latency is at the shorter end of the typical 2-8 week spectrum for DRESS but is still plausible. Aromatic anticonvulsants like lamotrigine are well-known causes.\n    *   **Epidemiology:** Lamotrigine is a common cause of severe cutaneous adverse reactions, including DRESS.\n    *   **Mechanism:** As an aromatic anticonvulsant, it is thought to form reactive metabolites that can trigger the reaction. It is a viable, but secondary, candidate compared to allopurinol given the ideal latency of the latter.\n\n3.  **Amoxicillin:**\n    *   **Latency:** A 23-day latency is within the general range for delayed hypersensitivity.\n    *   **Epidemiology:** While aminopenicillins like amoxicillin can cause delayed rashes, they are a much less common cause of true DRESS compared to allopurinol and aromatic anticonvulsants. They are more typically associated with benign maculopapular exanthems.\n    *   **Likelihood:** Amoxicillin is the least likely culprit among the three.\n\n**Conclusion:**\nBased on the analysis, allopurinol is the most likely offender due to its classic latency period and high epidemiological risk. Lamotrigine is a plausible second candidate. Amoxicillin is the least likely. This corresponds to the ranking: Allopurinol $>$ Lamotrigine $>$ Amoxicillin.\n\nOption A provides this exact ranking and the correct justification: a 35-day latency is classic for allopurinol, a 15-day latency is plausible but short for lamotrigine, and aminopenicillins are rare causes of DRESS. The other options contain incorrect reasoning. For instance, B incorrectly prioritizes lamotrigine despite allopurinol's ideal latency. C incorrectly elevates amoxicillin. D incorrectly suggests the shortest interval is always best. E incorrectly ranks amoxicillin over lamotrigine and mischaracterizes lamotrigine's association with DRESS.\n\nTherefore, option A presents the most accurate clinical and mechanistic reasoning.",
            "answer": "$$\n\\boxed{A}\n$$"
        },
        {
            "introduction": "For patients with severe manifestations of DRESS, systemic corticosteroids are a cornerstone of treatment. However, their use demands precise pharmacological calculations to ensure both efficacy and safety. This final practice problem  focuses on these essential skills, guiding you through weight-based initial dosing, converting between different corticosteroid potencies, and designing a structured therapeutic taper over several weeks.",
            "id": "4436909",
            "problem": "A patient with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) presents with severe hepatic involvement. Systemic corticosteroids are indicated. A standard initial dosing approach is to use a weight-based daily dose of prednisone. For equivalence, prednisone and methylprednisolone have a well-established relative anti-inflammatory potency that can be treated as a fixed ratio at therapeutic doses. Linear tapering over weeks can be modeled as an arithmetic sequence of weekly step-downs in the daily dose, holding the dose constant within each week. Assume each week has $7$ days.\n\nGiven:\n- Body weight is $70\\,\\mathrm{kg}$.\n- Initial prednisone dosing is $1.0\\,\\mathrm{mg/kg/day}$.\n- Prednisone to methylprednisolone potency ratio is $1.25:1$ (that is, $1.25$ parts prednisone equals $1$ part methylprednisolone for the same anti-inflammatory effect).\n- On day $1$, convert the calculated prednisone dose to an equivalent methylprednisolone dose and administer methylprednisolone thereafter.\n- Implement a linear taper of the methylprednisolone daily dose over $8$ weeks to reach $0\\,\\mathrm{mg/day}$ at the start of week $9$, by reducing the daily dose by an equal amount at the start of each week; keep the daily dose constant within each week.\n\nUsing these assumptions and definitions, compute the total cumulative methylprednisolone dose administered over the entire $8$-week taper. Express your final answer in $\\mathrm{mg}$ and round your answer to four significant figures.",
            "solution": "This problem requires calculating the total cumulative dose of methylprednisolone administered over an 8-week taper. The solution involves several steps: calculating the initial dose, converting between corticosteroids, modeling the linear taper, and summing the dose over the entire period.\n\n**Step 1: Calculate the initial daily dose of prednisone.**\nThe initial prednisone dose is based on the patient's weight and the prescribed dosing rate.\n*   Patient's weight ($W$): $70\\,\\mathrm{kg}$\n*   Dosing rate ($R_{pred}$): $1.0\\,\\mathrm{mg/kg/day}$\nThe initial daily prednisone dose ($D_{pred}$) is:\n$$\nD_{pred} = W \\times R_{pred} = 70\\,\\mathrm{kg} \\times 1.0\\,\\mathrm{mg/kg/day} = 70\\,\\mathrm{mg/day}\n$$\n\n**Step 2: Convert the prednisone dose to an equivalent methylprednisolone dose.**\nThe problem states a prednisone-to-methylprednisolone potency ratio of $1.25:1$. This means $1.25\\,\\mathrm{mg}$ of prednisone has the same anti-inflammatory effect as $1\\,\\mathrm{mg}$ of methylprednisolone. The initial daily dose of methylprednisolone ($d_1$), which is the dose for the first week, is calculated as:\n$$\nd_1 = \\frac{D_{pred}}{1.25} = \\frac{70\\,\\mathrm{mg/day}}{1.25} = 56\\,\\mathrm{mg/day}\n$$\n\n**Step 3: Model the linear dose taper.**\nThe taper reduces the daily dose to $0\\,\\mathrm{mg/day}$ at the start of week 9. This means the dose is reduced over 8 weekly steps, starting from the dose of week 1 ($d_1 = 56\\,\\mathrm{mg/day}$). The weekly dose reduction amount ($\\Delta$) is constant.\n$$\n\\Delta = \\frac{\\text{Initial daily dose}}{\\text{Number of taper steps}} = \\frac{56\\,\\mathrm{mg/day}}{8\\,\\text{weeks}} = 7\\,\\mathrm{mg/day/week}\n$$\nThe daily dose for each of the 8 weeks of therapy forms an arithmetic sequence:\n*   Week 1 ($d_1$): $56\\,\\mathrm{mg/day}$\n*   Week 2 ($d_2$): $56 - 7 = 49\\,\\mathrm{mg/day}$\n*   Week 3 ($d_3$): $49 - 7 = 42\\,\\mathrm{mg/day}$\n*   Week 4 ($d_4$): $42 - 7 = 35\\,\\mathrm{mg/day}$\n*   Week 5 ($d_5$): $35 - 7 = 28\\,\\mathrm{mg/day}$\n*   Week 6 ($d_6$): $28 - 7 = 21\\,\\mathrm{mg/day}$\n*   Week 7 ($d_7$): $21 - 7 = 14\\,\\mathrm{mg/day}$\n*   Week 8 ($d_8$): $14 - 7 = 7\\,\\mathrm{mg/day}$\n\n**Step 4: Calculate the total cumulative dose.**\nThe total dose is the sum of the doses administered over the 8 weeks. Since the daily dose is constant within each week (7 days), the total dose is 7 times the sum of the daily dose values for each week. The sum of the daily dose values ($S_8$) can be calculated using the formula for an arithmetic series, $S_n = \\frac{n}{2}(a_1 + a_n)$:\n$$\nS_8 = \\sum_{k=1}^{8} d_k = \\frac{8}{2}(d_1 + d_8) = 4 \\times (56\\,\\mathrm{mg} + 7\\,\\mathrm{mg}) = 4 \\times 63\\,\\mathrm{mg} = 252\\,\\mathrm{mg}\n$$\nThe total cumulative dose, $D_{total}$, administered over the 8-week period is:\n$$\nD_{total} = 7\\,\\text{days/week} \\times \\left( \\sum_{k=1}^{8} d_k \\right) \\text{value} = 7 \\times 252\\,\\mathrm{mg} = 1764\\,\\mathrm{mg}\n$$\nThe result, $1764$, has four significant figures, so no rounding is needed.",
            "answer": "$$\n\\boxed{1764}\n$$"
        }
    ]
}